SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Columbia Wanger Asset Management LLC – ‘SC 13G’ on 2/5/09 re: Price T Rowe Associates Inc/MD

On:  Thursday, 2/5/09, at 10:17am ET   ·   Accession #:  908733-9-61   ·   File #:  5-39706

Previous ‘SC 13G’:  ‘SC 13G/A’ on 1/16/09   ·   Next:  ‘SC 13G’ on 2/5/09   ·   Latest:  ‘SC 13G’ on 2/13/18

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer

 2/05/09  Columbia Wanger Asset Mgmt LLC    SC 13G                 1:36K  Price T Rowe Associates Inc/MD

Statement of Beneficial Ownership   —   Schedule 13G
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: SC 13G      Alexion Pharmaceuticals 13G                         HTML     24K 


This is an HTML Document rendered as filed.  [ Alternative Formats ]



SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

____________________
 

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No.)*

alexion pharmaceuticals inc
___________________________________________________________
(Name of Issuer)
 
 

COMMON STOCK
___________________________________________________________
(Title of Class of Securities)

015351109

______________________________

(CUSIP Number)
 

December 31, 2008

___________________________________________________________
(Date of Event Which Requires Filing of this Statement)
 
 

Check the appropriate box to designate the Rule pursuant to which this Schedule is filed:
 

[X]     Rule 13d – 1(b)
[ ]     Rule 13d – 1(c)
[ ]     Rule 13d – 1(d)
 

*     The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes.)


 

CUSIP No 015351109

 

13G

 

Page 2 of 6 Pages



1

NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY):

 

Columbia Wanger Asset Management, L.P.                      04-3519872

2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)                                        (a) [ ]

                                        (b) [ ]

3

SEC USE ONLY

4

CITIZENSHIP OR PLACE OF ORGANIZATION

Delaware

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH

5 SOLE VOTING POWER

3,966,800

6 SHARED VOTING POWER

0

7 SOLE DISPOSITIVE POWER

4,091,100

8 SHARED DISPOSITIVE POWER

0

9

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

4,091,100

10

CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions)

[ ]

11

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
 

5.25%

12

TYPE OF REPORTING PERSON (See Instructions)

IA




Item 1(a).     Name of Issuer:

Alexion Pharmaceuticals

Item 1(b).     Address of Issuer’s Principal Executive Offices:

352 Knotter Drive
Cheshire, CT 06511

Item 2(a).     Name of Person Filing:

Columbia Wanger Asset Management, L.P.

Item 2(b).     Address of Principal Business Office or, if None, Residence:

227 West Monroe Street, Suite 3000, Chicago, IL 60606.

Item 2(c).     Citizenship:

Delaware

Item 2(d).     Title of Class of Securities:

Common Stock


Item 2(e).     CUSIP Number:

015351109

Item 3.          If This Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b) or (c),

Check Whether the Person Filing is a:

(a)     

[ ] Broker or dealer registered under Section 15 of the Exchange Act.


(b)     

[ ] Bank as defined in Section 3(a)(6) of the Exchange Act.

(c)     

[ ] Insurance company as defined in Section 3(a)(19) of the Exchange Act.


(d)     

[ ] Investment company registered under Section 8 of the Investment Company Act.


(e)     

[ X ] An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E).


(f)     

[ ] An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F).


(g)     

[ ] A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G).

(h)     

[ ] A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act.

(i)     

[ ] A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act.

(j)     

[ ] Group, in accordance with Rule 13d-1(b)(1)(ii)(J).



If this statement is filed pursuant to Rule 13d-1(c), check this box. [ ]

Item 4.          Ownership:

With respect to the beneficial ownership of the reporting person, see Items 5 through 11 of the cover pages to this Schedule 13G, which are incorporated herein by reference.

Item 5.          Ownership of 5 Percent or Less of a Class:

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [ ].

Item 6.          Ownership or More than Five Percent on Behalf of Another Person:

Not Applicable.


Item 7.          Identification and Classification of the Subsidiary Which Acquired the

Security Being Reported on by the Parent Holding Company or Control
Person
:

Not Applicable.

Item 8.          Identification and Classification of Members of the Group:

Not Applicable.

Item 9.          Notice of Dissolution of Group:

Not Applicable.


Item 10.     Certification:

By signing below each of the undersigned certifies that, to the best of such undersigned’s knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

SIGNATURE
 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated:     January 27, 2009
 

Columbia Wanger Asset Management, L.P.

By:      /s/ Bruce H. Lauer
     _____________________

Bruce H. Lauer

Senior Vice President and Secretary,

WAM Acquisition GP, Inc., General Partner


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘SC 13G’ Filing    Date    Other Filings
Filed on:2/5/0913F-HR,  SC 13G,  SC 13G/A
1/27/09
12/31/0813F-HR,  13F-HR/A
 List all Filings 
Top
Filing Submission 0000908733-09-000061   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Thu., Mar. 28, 3:06:56.1pm ET